Tirzepatide
99%
- Product Code: 238819
Alias:
Telpopeptide
CAS:
2023788-19-2
| Molecular Weight: | 4813.45(free) g./mol | Molecular Formula: | C₂₂₅H₃₄₈N₄₈O₆₈(free) |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C |
Product Description:
Used primarily in the management of type 2 diabetes, the compound enhances glycemic control by mimicking incretin hormones that stimulate insulin secretion in response to meals. It acts on both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, providing a dual mechanism that improves blood sugar regulation more effectively than single-receptor agents. Additionally, it reduces appetite and food intake by acting on centers in the brain that regulate hunger, leading to significant weight loss in patients. Due to this effect, it is also utilized in chronic weight management for individuals with obesity, particularly those with related comorbidities such as hypertension or dyslipidemia. Its once-weekly injectable formulation improves patient adherence compared to daily treatments.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 1mg | 10-20 days | ฿24,000.00 |
+
-
|
| 5mg | 10-20 days | ฿72,000.00 |
+
-
|
Tirzepatide
Used primarily in the management of type 2 diabetes, the compound enhances glycemic control by mimicking incretin hormones that stimulate insulin secretion in response to meals. It acts on both the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, providing a dual mechanism that improves blood sugar regulation more effectively than single-receptor agents. Additionally, it reduces appetite and food intake by acting on centers in the brain that regulate hunger, leading to significant weight loss in patients. Due to this effect, it is also utilized in chronic weight management for individuals with obesity, particularly those with related comorbidities such as hypertension or dyslipidemia. Its once-weekly injectable formulation improves patient adherence compared to daily treatments.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :